MENU
+Compare
DYN
Stock ticker: NASDAQ
AS OF
Aug 11, 03:19 PM (EDT)
Price
$11.03
Change
-$0.16 (-1.43%)
Capitalization
1.59B

DYN Dyne Therapeutics Forecast, Technical & Fundamental Analysis

Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases... Show more

DYN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for DYN with price predictions
Aug 08, 2025

DYN's RSI Oscillator peaks and leaves overbought zone

The 10-day RSI Indicator for DYN moved out of overbought territory on August 07, 2025. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 32 instances where the indicator moved out of the overbought zone. In of the 32 cases the stock moved lower in the days that followed. This puts the odds of a move down at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 59 cases where DYN's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where DYN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

DYN broke above its upper Bollinger Band on August 06, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on July 16, 2025. You may want to consider a long position or call options on DYN as a result. In of 80 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for DYN just turned positive on July 16, 2025. Looking at past instances where DYN's MACD turned positive, the stock continued to rise in of 41 cases over the following month. The odds of a continued upward trend are .

DYN moved above its 50-day moving average on August 06, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where DYN advanced for three days, in of 267 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 222 cases where DYN Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.779) is normal, around the industry mean (18.662). P/E Ratio (0.000) is within average values for comparable stocks, (54.033). DYN's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.909). Dividend Yield (0.000) settles around the average of (0.049) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (286.048).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. DYN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. DYN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
DYN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

DYN is expected to report earnings to fall 11.49% to -85 cents per share on October 30

Dyne Therapeutics DYN Stock Earnings Reports
Q3'25
Est.
$-0.86
Q2'25
Missed
by $0.03
Q1'25
Missed
by $0.20
Q4'24
Beat
by $0.06
Q3'24
Missed
by $0.25
The last earnings report on July 28 showed earnings per share of -97 cents, missing the estimate of -93 cents. With 748.65K shares outstanding, the current market capitalization sits at 1.59B.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Electric Utilities
Address
1560 Trapelo Road
Phone
+1 781 786-8230
Employees
141
Web
https://www.dyne-tx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ANVIX28.040.18
+0.65%
Virtus NFJ Large-Cap Value Fund Inst
FBLEX14.290.09
+0.63%
Fidelity Series Stk Selec Lg Cp Val
UIPMX33.470.21
+0.63%
Victory Precious Metals & Minerals Instl
FFNIX13.780.02
+0.15%
Fidelity Advisor Asset Manager 40% I
EAAAX16.22-0.04
-0.25%
Gabelli Entpr Mergers & Acquisitions AAA

DYN and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, DYN has been loosely correlated with RNA. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if DYN jumps, then RNA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DYN
1D Price
Change %
DYN100%
N/A
RNA - DYN
58%
Loosely correlated
-2.59%
CRNX - DYN
54%
Loosely correlated
-3.69%
XNCR - DYN
53%
Loosely correlated
-1.23%
SYRE - DYN
52%
Loosely correlated
N/A
IDYA - DYN
50%
Loosely correlated
+3.08%
More